US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Mesoblast

14.02

-0.3400-2.37%

Post-market: 14.520.5000+3.57%19:43 EDT

Volume:1.23M

Turnover:17.48M

Market Cap:1.80B

PE:-19.05

High:14.93

Open:14.80

Low:14.02

Close:14.36

52wk High:21.50

52wk Low:9.61

Shares:128.30M

Float Shares:78.65M

Volume Ratio:5.93

T/O Rate:1.56%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7359

EPS(LYR):-0.8457

ROE:-18.22%

ROA:-6.16%

PB:3.13

PE(LYR):-16.58

Loading ...

Overview Company News Filings

Independent Study Presented at American Society of Hematology (ASH) Annual Meeting Concludes Remestemcel-L Superior to Ruxolitinib in Clinical Outcomes as Treatment for SR-aGvHD

Mesoblast Participation at Piper Sandler Conference

Mesoblast’s AGM Results: All Resolutions Passed on November 25, 2025

BRIEF-Mesoblast Expects Gross Revenue Of More Than $30.0 Mln From Sales Of Ryoncil For Quarter Ending Dec 31

Mesoblast Achieves FDA Approval for Ryoncil®

Mesoblast Ltd - for Quarter Ending December 31, 2025, Expects Gross Revenue of More Than US$30.0 Million From Sales of Ryoncil

THOMSON REUTERS

Mesoblast Raised to Buy From Hold by Jefferies

Mesoblast upgraded to Buy from Hold at Jefferies

Mesoblast Reports 37% Quarter-on-Quarter Revenue Growth From Ryoncil; Shares Up 3%

MT Newswires Live

Press Release: Mesoblast Trading Update at Annual General Meeting Highlights Continued Strong Growth in Ryoncil(R) Revenue

Mesoblast to Conduct Pivotal Ryoncil Trial in Adults With Severe Acute Graft Versus Host Disease

MT Newswires Live

Mesoblast and BMT CTN to Initiate Pivotal Trial of Ryoncil® as Part of First-Line Regimen in Adults with Severe Acute GVHD Refractory to Steroids

Mesoblast appoints James O’Brien as CFO

Mesoblast Appoints James O'Brien CFO

MT Newswires Live

Press Release: James M. O'Brien Appointed Chief Financial Officer at Mesoblast

BRIEF-Mesoblast Appoints James M. O'brien As U.S.-Based CFO

Mesoblast Appoints New CFO Amidst Commercial Transition

Mesoblast Appoints CFO

MT Newswires Live

Mesoblast Ltd - Appoints James M. O'brien as US-Based CFO

THOMSON REUTERS

Mesoblast to Meet With FDA Next Month to Discuss Rexlemestrocel-L and Opioid Cessation

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MESO/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MESO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MESO\",,,,,undefined,":{"symbol":"MESO","market":"US","secType":"STK","nameCN":"Mesoblast","latestPrice":14.02,"timestamp":1774296000000,"preClose":14.36,"halted":0,"volume":1229163,"hourTrading":{"tag":"盘后","latestPrice":14.52,"preClose":14.02,"latestTime":"19:43 EDT","volume":8129,"amount":115251.16,"timestamp":1774309388292,"change":0.5,"changeRate":0.035663,"amplitude":0.032097},"delay":0,"changeRate":-0.023676880222841215,"floatShares":78649063,"shares":128296718,"eps":-0.73592,"marketStatus":"Closed","change":-0.34,"latestTime":"03-23 16:00:00 EDT","open":14.8,"high":14.93,"low":14.02,"amount":17476158.409242,"amplitude":0.06337,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.73592,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774339200000},"marketStatusCode":5,"adr":1,"adrRate":10,"listingDate":1447390800000,"exchange":"NASDAQ","adjPreClose":14.36,"postHourTrading":{"tag":"盘后","latestPrice":14.52,"preClose":14.02,"latestTime":"19:43 EDT","volume":8129,"amount":115251.16,"timestamp":1774309388292,"change":0.5,"changeRate":0.035663,"amplitude":0.032097},"volumeRatio":5.933416,"impliedVol":0.7603,"impliedVolPercentile":0.7371},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MESO\",,,,,undefined,":{"symbol":"MESO","floatShares":78649063,"roa":"-6.16%","roe":"-18.22%","lyrEps":-0.84569,"volumeRatio":5.933416,"shares":128296718,"dividePrice":0,"high":14.93,"amplitude":0.06337,"preClose":14.36,"low":14.02,"week52Low":9.61,"pbRate":"3.13","psRate":"27.51","week52High":21.5,"institutionHeld":0.0363,"latestPrice":14.02,"eps":-0.73592,"divideRate":0,"volume":1229163,"delay":0,"ttmEps":-0.73592,"open":14.8,"prevYearClose":18.04,"prevWeekClose":14.36,"prevMonthClose":15.85,"prevQuarterClose":18.04,"fiveDayClose":14.63,"twentyDayClose":16.68,"sixtyDayClose":19.19},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MESO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-26","symbol":"MESO","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-28","symbol":"MESO","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756411200000,"name":null,"time":"Post Market","dateTimestamp":1756353600000,"actualEps":null},{"market":"US","date":"2025-02-26","symbol":"MESO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740546000000,"reportTimeType":"post","actualEps":null},{"date":"2024-10-30","symbol":"MESO","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1730318400000,"name":null,"time":"Post Market","dateTimestamp":1730260800000,"actualEps":null},{"market":"US","date":"2024-08-29","symbol":"MESO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1724904000000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MESO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MESO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1743480000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MESO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MESO","date":"2026-03-20","current":-19.94782,"percent":0.123366,"low":-28.533871,"twenty":-15.021134,"median":-8.145965,"eighty":-4.836613,"high":-1.760343,"avg":-9.991556,"sd":6.469011,"marketCap":1874161791.28},"quantilePoints":[{"date":"2021-03-26","current":-11.488779,"twenty":-17.247652,"median":-8.529752,"eighty":-5.546595,"marketCap":1127152618.61},{"date":"2021-04-01","current":-11.151567,"twenty":-17.247652,"median":-8.546537,"eighty":-5.546595,"marketCap":1094069133.91},{"date":"2021-04-09","current":-11.229979,"twenty":-17.248804,"median":-8.596533,"eighty":-5.543538,"marketCap":1101762040.71},{"date":"2021-04-16","current":-11.850329,"twenty":-17.248804,"median":-8.603124,"eighty":-5.543538,"marketCap":1162623979.74},{"date":"2021-04-23","current":-10.680467,"twenty":-17.248804,"median":-8.613905,"eighty":-5.543538,"marketCap":1047849972.92},{"date":"2021-04-30","current":-9.951321,"twenty":-17.247652,"median":-8.64541,"eighty":-5.546595,"marketCap":976314098.47},{"date":"2021-05-07","current":-9.020264,"twenty":-17.247652,"median":-8.724413,"eighty":-5.546595,"marketCap":884969155.61},{"date":"2021-05-14","current":-8.936114,"twenty":-17.247652,"median":-8.776195,"eighty":-5.546595,"marketCap":876713204.54},{"date":"2021-05-21","current":-9.606567,"twenty":-17.247652,"median":-8.806275,"eighty":-5.546595,"marketCap":942490703.13},{"date":"2021-05-28","current":-10.331492,"twenty":-17.247652,"median":-8.870186,"eighty":-5.546595,"marketCap":1013612399.08},{"date":"2021-06-04","current":-8.478517,"twenty":-17.247652,"median":-8.874709,"eighty":-5.546595,"marketCap":927219112.8},{"date":"2021-06-11","current":-9.793515,"twenty":-17.247652,"median":-8.939667,"eighty":-5.546595,"marketCap":1071028589.57},{"date":"2021-06-18","current":-10.279959,"twenty":-17.247652,"median":-9.020264,"eighty":-5.577398,"marketCap":1124226538.92},{"date":"2021-06-25","current":-9.71719,"twenty":-17.2465,"median":-9.114185,"eighty":-5.608942,"marketCap":1062681623.98},{"date":"2021-07-02","current":-9.14295,"twenty":-17.2465,"median":-9.130968,"eighty":-5.653203,"marketCap":999882146.5},{"date":"2021-07-09","current":-8.940615,"twenty":-17.2465,"median":-9.130968,"eighty":-5.669555,"marketCap":977754639.25},{"date":"2021-07-16","current":-8.352931,"twenty":-17.2465,"median":-9.137259,"eighty":-5.714809,"marketCap":913484850.75},{"date":"2021-07-23","current":-8.617099,"twenty":-17.2465,"median":-9.137259,"eighty":-5.726111,"marketCap":942374599.06},{"date":"2021-07-30","current":-8.154347,"twenty":-17.2465,"median":-9.137259,"eighty":-5.753903,"marketCap":891767494.86},{"date":"2021-08-06","current":-8.594928,"twenty":-17.2465,"median":-9.137259,"eighty":-5.785979,"marketCap":939949905.17},{"date":"2021-08-13","current":-8.907922,"twenty":-17.2465,"median":-9.137259,"eighty":-5.823121,"marketCap":974179256.47},{"date":"2021-08-20","current":-7.831479,"twenty":-17.2465,"median":-9.137259,"eighty":-5.849334,"marketCap":856458368.99},{"date":"2021-08-27","current":-8.527848,"twenty":-17.2465,"median":-9.137259,"eighty":-5.874762,"marketCap":932614045.22},{"date":"2021-09-03","current":-8.348028,"twenty":-17.2465,"median":-9.141839,"eighty":-5.906396,"marketCap":824876974.32},{"date":"2021-09-10","current":-8.16771,"twenty":-17.2465,"median":-9.141839,"eighty":-5.942665,"marketCap":807059577.04},{"date":"2021-09-17","current":-7.822879,"twenty":-17.2465,"median":-9.141839,"eighty":-5.987308,"marketCap":772986467.64},{"date":"2021-09-24","current":-8.175349,"twenty":-17.2465,"median":-9.141839,"eighty":-6.023209,"marketCap":807814368.43},{"date":"2021-10-01","current":-7.783744,"twenty":-17.2465,"median":-9.141839,"eighty":-6.050751,"marketCap":769119531.1},{"date":"2021-10-08","current":-7.386162,"twenty":-17.2465,"median":-9.141839,"eighty":-6.067515,"marketCap":729834059.96},{"date":"2021-10-15","current":-7.787078,"twenty":-17.2465,"median":-9.141839,"eighty":-6.127705,"marketCap":769448926.74},{"date":"2021-10-22","current":-8.255299,"twenty":-17.2465,"median":-9.141839,"eighty":-6.153013,"marketCap":815714349.97},{"date":"2021-10-29","current":-7.824359,"twenty":-17.245349,"median":-9.140729,"eighty":-6.200698,"marketCap":773132681.43},{"date":"2021-11-05","current":-8.277829,"twenty":-17.245349,"median":-9.140729,"eighty":-6.275713,"marketCap":817940595.29},{"date":"2021-11-12","current":-8.163493,"twenty":-17.245349,"median":-9.140729,"eighty":-6.310405,"marketCap":806642949.1},{"date":"2021-11-19","current":-8.184017,"twenty":-17.245349,"median":-9.14295,"eighty":-6.376906,"marketCap":808670944.78},{"date":"2021-11-26","current":-8.115899,"twenty":-17.245349,"median":-9.14295,"eighty":-6.429742,"marketCap":786527984.91},{"date":"2021-12-03","current":-7.301071,"twenty":-17.245349,"median":-9.14295,"eighty":-6.562113,"marketCap":707561392.26},{"date":"2021-12-10","current":-8.392226,"twenty":-17.245349,"median":-9.14295,"eighty":-6.626978,"marketCap":813307428.47},{"date":"2021-12-17","current":-6.556749,"twenty":-17.245349,"median":-9.14295,"eighty":-6.639711,"marketCap":635427661.92},{"date":"2021-12-23","current":-6.69853,"twenty":-17.245349,"median":-9.14295,"eighty":-6.642158,"marketCap":649167874.45},{"date":"2021-12-31","current":-6.856135,"twenty":-17.245349,"median":-9.14295,"eighty":-6.661797,"marketCap":664441696.36},{"date":"2022-01-07","current":-6.330136,"twenty":-17.244197,"median":-9.141839,"eighty":-6.685608,"marketCap":613466174.26},{"date":"2022-01-14","current":-6.329384,"twenty":-17.244197,"median":-9.141839,"eighty":-6.685608,"marketCap":613393311.18},{"date":"2022-01-21","current":-5.701095,"twenty":-17.244197,"median":-9.141839,"eighty":-6.685608,"marketCap":552504511.13},{"date":"2022-01-28","current":-5.111939,"twenty":-17.244197,"median":-9.141839,"eighty":-6.685608,"marketCap":495408213.04},{"date":"2022-02-04","current":-5.400062,"twenty":-17.244197,"median":-9.141839,"eighty":-6.685608,"marketCap":523330798.95},{"date":"2022-02-11","current":-5.508973,"twenty":-17.244197,"median":-9.141839,"eighty":-6.685608,"marketCap":533885570.78},{"date":"2022-02-18","current":-5.390624,"twenty":-17.244197,"median":-9.141839,"eighty":-6.685608,"marketCap":522416101.06},{"date":"2022-02-25","current":-5.218408,"twenty":-17.244197,"median":-9.141839,"eighty":-6.685608,"marketCap":507046578.78},{"date":"2022-03-04","current":-5.086589,"twenty":-17.244197,"median":-9.141839,"eighty":-6.685608,"marketCap":494238468.04},{"date":"2022-03-11","current":-5.597581,"twenty":-17.244197,"median":-9.141839,"eighty":-6.65015,"marketCap":543888931.44},{"date":"2022-03-18","current":-5.942028,"twenty":-17.244197,"median":-9.141839,"eighty":-6.628319,"marketCap":577357104.68},{"date":"2022-03-25","current":-5.673532,"twenty":-17.244197,"median":-9.141839,"eighty":-6.608028,"marketCap":551268699.89},{"date":"2022-04-01","current":-5.714731,"twenty":-17.244197,"median":-9.141839,"eighty":-6.560627,"marketCap":555271886.38},{"date":"2022-04-08","current":-5.65913,"twenty":-17.244197,"median":-9.137259,"eighty":-6.477378,"marketCap":549869340.29},{"date":"2022-04-14","current":-5.674305,"twenty":-17.244197,"median":-9.097852,"eighty":-6.415736,"marketCap":551343880.86},{"date":"2022-04-22","current":-5.440371,"twenty":-17.244197,"median":-9.029914,"eighty":-6.348321,"marketCap":528613685.55},{"date":"2022-04-29","current":-5.10283,"twenty":-17.244197,"median":-8.940141,"eighty":-6.32797,"marketCap":495816493.51},{"date":"2022-05-06","current":-4.828644,"twenty":-17.244197,"median":-8.910034,"eighty":-6.2864,"marketCap":469175193.46},{"date":"2022-05-13","current":-4.674206,"twenty":-17.244197,"median":-8.84188,"eighty":-6.268346,"marketCap":454169213.31},{"date":"2022-05-20","current":-4.723622,"twenty":-17.244197,"median":-8.84188,"eighty":-6.221933,"marketCap":458970701.99},{"date":"2022-05-27","current":-4.737002,"twenty":-17.244197,"median":-8.84188,"eighty":-6.155134,"marketCap":460270785.46},{"date":"2022-06-03","current":-4.589905,"twenty":-17.244197,"median":-8.84188,"eighty":-6.141993,"marketCap":422051001.52},{"date":"2022-06-10","current":-3.885402,"twenty":-17.244197,"median":-8.84188,"eighty":-6.101247,"marketCap":357270480.65},{"date":"2022-06-17","current":-3.326322,"twenty":-17.244197,"median":-8.84188,"eighty":-6.065673,"marketCap":305861942},{"date":"2022-06-24","current":-3.41411,"twenty":-17.245349,"median":-8.857915,"eighty":-6.04967,"marketCap":313934247.29},{"date":"2022-07-01","current":-3.262423,"twenty":-17.245349,"median":-8.857915,"eighty":-6.024422,"marketCap":299986369.81},{"date":"2022-07-08","current":-4.02801,"twenty":-17.245349,"median":-8.857915,"eighty":-6.000916,"marketCap":370383594.48},{"date":"2022-07-15","current":-3.966973,"twenty":-17.245349,"median":-8.857915,"eighty":-5.951074,"marketCap":364771147.02},{"date":"2022-07-22","current":-4.668067,"twenty":-17.245349,"median":-8.857915,"eighty":-5.918534,"marketCap":429238087.46},{"date":"2022-07-29","current":-4.610708,"twenty":-17.245349,"median":-8.857915,"eighty":-5.888804,"marketCap":423963852.65},{"date":"2022-08-05","current":-4.531359,"twenty":-17.245349,"median":-8.857915,"eighty":-5.862603,"marketCap":416667470.01},{"date":"2022-08-12","current":-5.006897,"twenty":-17.245349,"median":-8.857915,"eighty":-5.841383,"marketCap":460394145.18},{"date":"2022-08-19","current":-4.730481,"twenty":-17.245349,"median":-8.857915,"eighty":-5.808957,"marketCap":434977236.83},{"date":"2022-08-26","current":-4.603716,"twenty":-17.245349,"median":-8.857915,"eighty":-5.783668,"marketCap":423320870.38},{"date":"2022-09-02","current":-4.689055,"twenty":-17.245349,"median":-8.857915,"eighty":-5.754286,"marketCap":428331098.72},{"date":"2022-09-09","current":-4.74422,"twenty":-17.245349,"median":-8.857915,"eighty":-5.741522,"marketCap":433370288.02},{"date":"2022-09-16","current":-5.022822,"twenty":-17.245349,"median":-8.857915,"eighty":-5.725498,"marketCap":458819713.33},{"date":"2022-09-23","current":-4.459503,"twenty":-17.245349,"median":-8.857915,"eighty":-5.718084,"marketCap":407362180.77},{"date":"2022-09-30","current":-4.05202,"twenty":-17.245349,"median":-8.857915,"eighty":-5.698868,"marketCap":370139856.33},{"date":"2022-10-07","current":-5.02874,"twenty":-17.245349,"median":-8.857915,"eighty":-5.673996,"marketCap":459360276.96},{"date":"2022-10-14","current":-4.997323,"twenty":-17.245349,"median":-8.857915,"eighty":-5.660693,"marketCap":456490453.44},{"date":"2022-10-21","current":-4.92643,"twenty":-17.245349,"median":-8.857915,"eighty":-5.64326,"marketCap":450014607.79},{"date":"2022-10-28","current":-4.567762,"twenty":-17.245349,"median":-8.857915,"eighty":-5.616596,"marketCap":417251365.29},{"date":"2022-11-04","current":-4.938653,"twenty":-17.245349,"median":-8.857915,"eighty":-5.603021,"marketCap":451131067.63},{"date":"2022-11-11","current":-4.935858,"twenty":-17.245349,"median":-8.857915,"eighty":-5.603021,"marketCap":450875808.13},{"date":"2022-11-18","current":-5.014425,"twenty":-17.168844,"median":-8.823942,"eighty":-5.582947,"marketCap":458052712.81},{"date":"2022-11-25","current":-5.86331,"twenty":-17.094265,"median":-8.814088,"eighty":-5.580687,"marketCap":501817266.78},{"date":"2022-12-02","current":-6.450051,"twenty":-17.041093,"median":-8.787884,"eighty":-5.580687,"marketCap":552034073.52},{"date":"2022-12-09","current":-5.534124,"twenty":-16.797492,"median":-8.750762,"eighty":-5.578026,"marketCap":473643513.2},{"date":"2022-12-16","current":-5.469981,"twenty":-16.634882,"median":-8.710469,"eighty":-5.559645,"marketCap":468153742.56},{"date":"2022-12-23","current":-5.163662,"twenty":-16.496803,"median":-8.645955,"eighty":-5.537865,"marketCap":441937112.69},{"date":"2022-12-30","current":-5.089021,"twenty":-16.380985,"median":-8.624537,"eighty":-5.525397,"marketCap":435548925.44},{"date":"2023-01-06","current":-5.271444,"twenty":-16.380985,"median":-8.624537,"eighty":-5.512496,"marketCap":451161778.68},{"date":"2023-01-13","current":-5.596665,"twenty":-16.380985,"median":-8.624537,"eighty":-5.506703,"marketCap":478996191.4},{"date":"2023-01-20","current":-5.537578,"twenty":-16.380985,"median":-8.624537,"eighty":-5.506703,"marketCap":473939163.19},{"date":"2023-01-27","current":-5.780758,"twenty":-16.380985,"median":-8.624537,"eighty":-5.506703,"marketCap":494751941.86},{"date":"2023-02-03","current":-6.262937,"twenty":-16.380985,"median":-8.624537,"eighty":-5.506703,"marketCap":536019734.68},{"date":"2023-02-10","current":-6.341292,"twenty":-16.380985,"median":-8.624537,"eighty":-5.506703,"marketCap":542725823.3},{"date":"2023-02-17","current":-5.719448,"twenty":-16.380985,"median":-8.624537,"eighty":-5.506703,"marketCap":489504634.83},{"date":"2023-02-24","current":-5.476733,"twenty":-16.380985,"median":-8.603273,"eighty":-5.505524,"marketCap":468731654.55},{"date":"2023-03-03","current":-5.407945,"twenty":-16.154038,"median":-8.577741,"eighty":-5.501139,"marketCap":454954204.13},{"date":"2023-03-10","current":-5.797611,"twenty":-16.081849,"median":-8.553716,"eighty":-5.490314,"marketCap":487735607.87},{"date":"2023-03-17","current":-5.540376,"twenty":-15.988186,"median":-8.508649,"eighty":-5.480895,"marketCap":466095156.69},{"date":"2023-03-24","current":-5.377389,"twenty":-15.792958,"median":-8.455363,"eighty":-5.474796,"marketCap":452383600.69},{"date":"2023-03-31","current":-5.548177,"twenty":-15.666846,"median":-8.428715,"eighty":-5.472167,"marketCap":466751496.68},{"date":"2023-04-06","current":-5.777123,"twenty":-15.493386,"median":-8.376347,"eighty":-5.472167,"marketCap":486012084.11},{"date":"2023-04-14","current":-5.989236,"twenty":-15.228266,"median":-8.309505,"eighty":-5.47162,"marketCap":503856483.58},{"date":"2023-04-21","current":-5.855172,"twenty":-14.801083,"median":-8.255299,"eighty":-5.47162,"marketCap":492578040.39},{"date":"2023-04-28","current":-4.986606,"twenty":-14.657685,"median":-8.216155,"eighty":-5.46337,"marketCap":419508178.81},{"date":"2023-05-05","current":-6.254866,"twenty":-14.567574,"median":-8.183408,"eighty":-5.46337,"marketCap":526203122.87},{"date":"2023-05-12","current":-7.056893,"twenty":-14.25969,"median":-8.163493,"eighty":-5.46337,"marketCap":593675275.45},{"date":"2023-05-19","current":-7.195349,"twenty":-14.054886,"median":-8.145965,"eighty":-5.46337,"marketCap":605323146.41},{"date":"2023-05-26","current":-7.022057,"twenty":-13.903097,"median":-8.134404,"eighty":-5.46337,"marketCap":571771016.33},{"date":"2023-06-02","current":-6.990022,"twenty":-13.820925,"median":-8.094403,"eighty":-5.46337,"marketCap":569162526.11},{"date":"2023-06-09","current":-6.878381,"twenty":-13.820925,"median":-8.050679,"eighty":-5.46337,"marketCap":560072171.11},{"date":"2023-06-16","current":-7.551563,"twenty":-13.820925,"median":-8.015725,"eighty":-5.46337,"marketCap":614886036},{"date":"2023-06-23","current":-7.924353,"twenty":-13.841202,"median":-7.989011,"eighty":-5.462064,"marketCap":645240438.69},{"date":"2023-06-30","current":-7.522586,"twenty":-13.841202,"median":-7.968911,"eighty":-5.462064,"marketCap":612526551.04},{"date":"2023-07-07","current":-7.465185,"twenty":-13.841202,"median":-7.926827,"eighty":-5.462064,"marketCap":607852684.78},{"date":"2023-07-14","current":-9.556217,"twenty":-13.841202,"median":-7.917179,"eighty":-5.462064,"marketCap":778114943.93},{"date":"2023-07-21","current":-9.2532,"twenty":-13.699277,"median":-7.910006,"eighty":-5.460759,"marketCap":753441776.68},{"date":"2023-07-28","current":-7.742686,"twenty":-13.438087,"median":-7.899028,"eighty":-5.460759,"marketCap":630448194.31},{"date":"2023-08-04","current":-3.07853,"twenty":-13.233127,"median":-7.853818,"eighty":-5.456828,"marketCap":250669312.4},{"date":"2023-08-11","current":-2.359106,"twenty":-12.847114,"median":-7.831479,"eighty":-5.44782,"marketCap":192090163.95},{"date":"2023-08-18","current":-2.307949,"twenty":-12.612689,"median":-7.793295,"eighty":-5.427473,"marketCap":187924739.21},{"date":"2023-08-25","current":-3.115116,"twenty":-12.441611,"median":-7.742686,"eighty":-5.40764,"marketCap":253648304.41},{"date":"2023-09-01","current":-2.959296,"twenty":-12.363486,"median":-7.671658,"eighty":-5.391223,"marketCap":242333754.61},{"date":"2023-09-07","current":-2.880504,"twenty":-12.237449,"median":-7.63427,"eighty":-5.382905,"marketCap":235881601.78},{"date":"2023-09-15","current":-2.75293,"twenty":-12.081337,"median":-7.604346,"eighty":-5.363998,"marketCap":225434681.7},{"date":"2023-09-22","current":-2.392948,"twenty":-11.954857,"median":-7.555725,"eighty":-5.353224,"marketCap":195956085.03},{"date":"2023-09-29","current":-2.485154,"twenty":-11.852581,"median":-7.522586,"eighty":-5.341685,"marketCap":203506797.28},{"date":"2023-10-06","current":-2.175801,"twenty":-11.741835,"median":-7.468627,"eighty":-5.327153,"marketCap":178174143.45},{"date":"2023-10-12","current":-2.390919,"twenty":-11.660569,"median":-7.455584,"eighty":-5.315681,"marketCap":195789975.94},{"date":"2023-10-20","current":-2.41855,"twenty":-11.554941,"median":-7.393383,"eighty":-5.3021,"marketCap":198052626.29},{"date":"2023-10-27","current":-2.286406,"twenty":-11.456048,"median":-7.386501,"eighty":-5.287928,"marketCap":187231497.29},{"date":"2023-11-03","current":-2.359072,"twenty":-11.426171,"median":-7.340884,"eighty":-5.257217,"marketCap":193182052.75},{"date":"2023-11-10","current":-2.360738,"twenty":-11.336133,"median":-7.315666,"eighty":-5.244566,"marketCap":193318507.03},{"date":"2023-11-17","current":-2.408104,"twenty":-11.272729,"median":-7.279292,"eighty":-5.216045,"marketCap":197197195.11},{"date":"2023-11-24","current":-2.509953,"twenty":-11.272729,"median":-7.247436,"eighty":-5.192345,"marketCap":205537588.74},{"date":"2023-12-01","current":-2.664819,"twenty":-11.272729,"median":-7.209879,"eighty":-5.168811,"marketCap":218219374.88},{"date":"2023-12-08","current":-1.86696,"twenty":-11.269252,"median":-7.195777,"eighty":-5.123043,"marketCap":152883469.8},{"date":"2023-12-15","current":-2.409815,"twenty":-11.269252,"median":-7.174737,"eighty":-5.090877,"marketCap":197337398.51},{"date":"2023-12-22","current":-2.481464,"twenty":-11.269252,"median":-7.158794,"eighty":-5.074967,"marketCap":203204602.53},{"date":"2023-12-29","current":-2.630538,"twenty":-11.272729,"median":-7.13957,"eighty":-5.053291,"marketCap":215412074.09},{"date":"2024-01-05","current":-2.454018,"twenty":-11.276205,"median":-7.111517,"eighty":-5.036274,"marketCap":200957107.47},{"date":"2024-01-12","current":-2.350321,"twenty":-11.276205,"median":-7.038345,"eighty":-5.022822,"marketCap":192465435.55},{"date":"2024-01-19","current":-2.439925,"twenty":-11.27867,"median":-6.997277,"eighty":-5.014102,"marketCap":199802979.59},{"date":"2024-01-26","current":-2.162363,"twenty":-11.276205,"median":-6.898946,"eighty":-4.997323,"marketCap":177073696.58},{"date":"2024-02-02","current":-2.193197,"twenty":-11.276205,"median":-6.812857,"eighty":-4.990067,"marketCap":179598728.37},{"date":"2024-02-09","current":-2.209052,"twenty":-11.276205,"median":-6.751639,"eighty":-4.95944,"marketCap":180897009.14},{"date":"2024-02-16","current":-2.298319,"twenty":-11.276205,"median":-6.714054,"eighty":-4.945204,"marketCap":188207073.6},{"date":"2024-02-23","current":-2.351033,"twenty":-11.276205,"median":-6.705554,"eighty":-4.938653,"marketCap":192523751.14},{"date":"2024-03-01","current":-2.664789,"twenty":-11.272729,"median":-6.69853,"eighty":-4.890239,"marketCap":194684140.6},{"date":"2024-03-08","current":-2.898034,"twenty":-11.272729,"median":-6.69853,"eighty":-4.868046,"marketCap":211724592.66},{"date":"2024-03-15","current":-3.248824,"twenty":-11.272729,"median":-6.69853,"eighty":-4.857044,"marketCap":237352591.25},{"date":"2024-03-22","current":-3.426599,"twenty":-11.272729,"median":-6.69853,"eighty":-4.839224,"marketCap":250340473.19},{"date":"2024-03-28","current":-5.651155,"twenty":-11.272729,"median":-6.69853,"eighty":-4.831114,"marketCap":412862079.99},{"date":"2024-04-05","current":-8.931781,"twenty":-11.276205,"median":-6.726848,"eighty":-4.829281,"marketCap":652538079.26},{"date":"2024-04-12","current":-8.73907,"twenty":-11.276205,"median":-6.785348,"eighty":-4.829281,"marketCap":638458919.78},{"date":"2024-04-19","current":-7.695336,"twenty":-11.276205,"median":-6.867258,"eighty":-4.829281,"marketCap":562205889.63},{"date":"2024-04-26","current":-9.449433,"twenty":-11.272729,"median":-6.992619,"eighty":-4.831114,"marketCap":690356657.99},{"date":"2024-05-03","current":-11.087079,"twenty":-11.272729,"median":-7.031544,"eighty":-4.831114,"marketCap":809999812.26},{"date":"2024-05-10","current":-10.99273,"twenty":-11.336133,"median":-7.070547,"eighty":-4.831114,"marketCap":803106838.25},{"date":"2024-05-17","current":-11.31732,"twenty":-11.338315,"median":-7.13957,"eighty":-4.831114,"marketCap":826820721.82},{"date":"2024-05-24","current":-12.157853,"twenty":-11.412713,"median":-7.166404,"eighty":-4.831114,"marketCap":888228404.32},{"date":"2024-05-31","current":-11.522689,"twenty":-11.448255,"median":-7.175489,"eighty":-4.831114,"marketCap":841824657.1},{"date":"2024-06-07","current":-10.873952,"twenty":-11.456983,"median":-7.196205,"eighty":-4.831114,"marketCap":794429166.67},{"date":"2024-06-14","current":-11.201588,"twenty":-11.456983,"median":-7.212852,"eighty":-4.831114,"marketCap":818365651.02},{"date":"2024-06-21","current":-10.658738,"twenty":-11.474525,"median":-7.247845,"eighty":-4.829281,"marketCap":778706058.45},{"date":"2024-06-28","current":-10.274263,"twenty":-11.485928,"median":-7.272169,"eighty":-4.828771,"marketCap":750617059.53},{"date":"2024-07-05","current":-11.612781,"twenty":-11.506495,"median":-7.302978,"eighty":-4.828771,"marketCap":848406578.31},{"date":"2024-07-12","current":-12.58396,"twenty":-11.540364,"median":-7.327198,"eighty":-4.828771,"marketCap":919358950.04},{"date":"2024-07-15","current":-12.334621,"twenty":-11.552324,"median":-7.337552,"eighty":-4.828771,"marketCap":901142747.73},{"date":"2024-08-02","current":-9.878349,"twenty":-11.60696,"median":-7.390625,"eighty":-4.802814,"marketCap":721692401.07},{"date":"2024-08-09","current":-9.751596,"twenty":-11.60696,"median":-7.446438,"eighty":-4.802814,"marketCap":712432087},{"date":"2024-08-16","current":-10.457506,"twenty":-11.60696,"median":-7.485787,"eighty":-4.802814,"marketCap":764004522.44},{"date":"2024-08-23","current":-10.166666,"twenty":-11.60696,"median":-7.522586,"eighty":-4.802814,"marketCap":742756289.59},{"date":"2024-08-30","current":-9.075988,"twenty":-11.60696,"median":-7.555725,"eighty":-4.802814,"marketCap":798287570.12},{"date":"2024-09-06","current":-8.239151,"twenty":-11.60696,"median":-7.612842,"eighty":-4.802814,"marketCap":724682800.7},{"date":"2024-09-13","current":-8.166474,"twenty":-11.60696,"median":-7.636285,"eighty":-4.802814,"marketCap":718290417.14},{"date":"2024-09-20","current":-9.143643,"twenty":-11.60696,"median":-7.670022,"eighty":-4.802814,"marketCap":804238205.9},{"date":"2024-09-27","current":-10.058593,"twenty":-11.60696,"median":-7.701654,"eighty":-4.802814,"marketCap":884713590.13},{"date":"2024-10-04","current":-13.233592,"twenty":-11.629772,"median":-7.710373,"eighty":-4.802814,"marketCap":1163973854.47},{"date":"2024-10-11","current":-12.655691,"twenty":-11.682947,"median":-7.783744,"eighty":-4.802814,"marketCap":1113143922.37},{"date":"2024-10-18","current":-12.614959,"twenty":-11.742455,"median":-7.819962,"eighty":-4.802814,"marketCap":1109561321.58},{"date":"2024-10-25","current":-10.88576,"twenty":-11.757336,"median":-7.84048,"eighty":-4.802814,"marketCap":957467920.81},{"date":"2024-10-31","current":-11.235359,"twenty":-11.757336,"median":-7.874583,"eighty":-4.802814,"marketCap":988217264.5},{"date":"2024-11-08","current":-12.070097,"twenty":-11.784852,"median":-7.965345,"eighty":-4.802095,"marketCap":1061637429.31},{"date":"2024-11-15","current":-13.2116,"twenty":-11.864941,"median":-7.981063,"eighty":-4.802095,"marketCap":1162039497.37},{"date":"2024-11-22","current":-12.715753,"twenty":-11.937479,"median":-8.01495,"eighty":-4.802095,"marketCap":1118426790.39},{"date":"2024-11-29","current":-14.925583,"twenty":-11.99311,"median":-8.030112,"eighty":-4.802095,"marketCap":1312794529.8},{"date":"2024-12-06","current":-13.869111,"twenty":-12.081059,"median":-8.030112,"eighty":-4.802095,"marketCap":1219871481},{"date":"2024-12-13","current":-15.238561,"twenty":-12.155278,"median":-8.030112,"eighty":-4.802095,"marketCap":1340322862.07},{"date":"2024-12-20","current":-19.655608,"twenty":-12.23132,"median":-8.030112,"eighty":-4.802095,"marketCap":1728828625.98},{"date":"2024-12-27","current":-22.849807,"twenty":-12.326174,"median":-8.030112,"eighty":-4.802095,"marketCap":2009777614.81},{"date":"2025-01-03","current":-25.510876,"twenty":-12.411203,"median":-8.030112,"eighty":-4.802095,"marketCap":2243834669.73},{"date":"2025-01-10","current":-22.570346,"twenty":-12.466025,"median":-8.015725,"eighty":-4.801375,"marketCap":1985197351.74},{"date":"2025-01-17","current":-22.179282,"twenty":-12.549792,"median":-8.015725,"eighty":-4.801375,"marketCap":1950800922.38},{"date":"2025-01-24","current":-25.888933,"twenty":-12.578823,"median":-8.015725,"eighty":-4.801375,"marketCap":2277087018.9},{"date":"2025-01-31","current":-28.533871,"twenty":-12.578823,"median":-8.015725,"eighty":-4.801375,"marketCap":2509725191.7},{"date":"2025-02-07","current":-28.40223,"twenty":-12.578823,"median":-8.015725,"eighty":-4.801375,"marketCap":2498146561.09},{"date":"2025-02-14","current":-25.473382,"twenty":-12.578823,"median":-8.015725,"eighty":-4.801375,"marketCap":2240536825.03},{"date":"2025-02-21","current":-24.552429,"twenty":-12.578823,"median":-8.015725,"eighty":-4.801375,"marketCap":2159533462.25},{"date":"2025-02-28","current":-19.36097,"twenty":-12.651932,"median":-8.015725,"eighty":-4.801375,"marketCap":2000975612.73},{"date":"2025-03-07","current":-16.329051,"twenty":-12.842677,"median":-8.01495,"eighty":-4.800656,"marketCap":1687623714.29},{"date":"2025-03-14","current":-15.98864,"twenty":-13.206567,"median":-8.044734,"eighty":-4.800656,"marketCap":1652441943.89},{"date":"2025-03-21","current":-17.32566,"twenty":-13.341088,"median":-8.065625,"eighty":-4.828644,"marketCap":1790624281.49},{"date":"2025-03-28","current":-15.661493,"twenty":-13.952659,"median":-8.10617,"eighty":-4.838446,"marketCap":1618630988.07},{"date":"2025-04-04","current":-13.788825,"twenty":-14.355873,"median":-8.136207,"eighty":-4.838446,"marketCap":1425088855.62},{"date":"2025-04-11","current":-12.028409,"twenty":-14.341809,"median":-8.147572,"eighty":-4.839224,"marketCap":1243148071.47},{"date":"2025-04-17","current":-12.935635,"twenty":-14.341809,"median":-8.147572,"eighty":-4.839224,"marketCap":1336910851.09},{"date":"2025-04-25","current":-14.150386,"twenty":-14.355873,"median":-8.146769,"eighty":-4.838446,"marketCap":1462456545.77},{"date":"2025-05-02","current":-14.563747,"twenty":-14.192636,"median":-8.146769,"eighty":-4.838446,"marketCap":1505177873.02},{"date":"2025-05-09","current":-13.519085,"twenty":-14.150386,"median":-8.146769,"eighty":-4.838446,"marketCap":1397210945.08},{"date":"2025-05-16","current":-13.671698,"twenty":-13.952659,"median":-8.146769,"eighty":-4.838446,"marketCap":1412983732.57},{"date":"2025-05-23","current":-13.516483,"twenty":-13.836248,"median":-8.146769,"eighty":-4.838446,"marketCap":1396942061.07},{"date":"2025-05-30","current":-13.539379,"twenty":-13.671698,"median":-8.146769,"eighty":-4.838446,"marketCap":1399308359.86},{"date":"2025-06-06","current":-14.149764,"twenty":-13.583651,"median":-8.146769,"eighty":-4.838446,"marketCap":1462392316.68},{"date":"2025-06-13","current":-14.464717,"twenty":-13.583651,"median":-8.146769,"eighty":-4.838446,"marketCap":1494942953.83},{"date":"2025-06-20","current":-13.080063,"twenty":-13.523144,"median":-8.145965,"eighty":-4.836613,"marketCap":1351837641.17},{"date":"2025-06-27","current":-13.345861,"twenty":-13.409123,"median":-8.145965,"eighty":-4.836613,"marketCap":1379308081.68},{"date":"2025-07-03","current":-13.115128,"twenty":-13.399806,"median":-8.145965,"eighty":-4.836613,"marketCap":1355461586.94},{"date":"2025-07-11","current":-13.424082,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":1387392370.04},{"date":"2025-07-18","current":-19.341572,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":1998970842.14},{"date":"2025-07-25","current":-20.609176,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2129978988.57},{"date":"2025-08-01","current":-18.707228,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":1933410756.22},{"date":"2025-08-08","current":-18.586009,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":1920882682.96},{"date":"2025-08-15","current":-20.174209,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2085024640.96},{"date":"2025-08-22","current":-18.921709,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":1955577544.79},{"date":"2025-08-29","current":-17.825409,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":1820722909.62},{"date":"2025-09-05","current":-17.285173,"twenty":-13.307105,"median":-8.145372,"eighty":-4.83478,"marketCap":1765542176.46},{"date":"2025-09-12","current":-18.42662,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":1882131813.83},{"date":"2025-09-19","current":-19.981179,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2040917601.56},{"date":"2025-09-26","current":-19.68854,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2011026851.06},{"date":"2025-10-03","current":-22.773018,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2326081544.74},{"date":"2025-10-10","current":-23.728478,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2423674201.28},{"date":"2025-10-17","current":-21.338263,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2179532802.55},{"date":"2025-10-24","current":-20.967839,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2141697005.01},{"date":"2025-10-31","current":-20.660836,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2110339040.57},{"date":"2025-11-07","current":-18.025651,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":1841176062.45},{"date":"2025-11-14","current":-18.276122,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":1866759684.73},{"date":"2025-11-21","current":-18.76734,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":1916933624.19},{"date":"2025-11-28","current":-22.235713,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2271200223.41},{"date":"2025-12-05","current":-22.117314,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2259106687.41},{"date":"2025-12-12","current":-23.191606,"twenty":-13.332018,"median":-8.145965,"eighty":-4.836613,"marketCap":2368837081.72},{"date":"2025-12-19","current":-24.205623,"twenty":-13.341465,"median":-8.145965,"eighty":-4.836613,"marketCap":2472410769.54},{"date":"2025-12-26","current":-24.40692,"twenty":-13.408826,"median":-8.145965,"eighty":-4.836613,"marketCap":2492971665.77},{"date":"2026-01-02","current":-23.214818,"twenty":-13.461548,"median":-8.145965,"eighty":-4.836613,"marketCap":2371207973.58},{"date":"2026-01-09","current":-25.794461,"twenty":-13.564038,"median":-8.145965,"eighty":-4.836613,"marketCap":2634697858.72},{"date":"2026-01-16","current":-22.384404,"twenty":-13.715077,"median":-8.145965,"eighty":-4.836613,"marketCap":2286387725.44},{"date":"2026-01-23","current":-23.14756,"twenty":-13.842821,"median":-8.145965,"eighty":-4.836613,"marketCap":2364338088.99},{"date":"2026-01-30","current":-22.371873,"twenty":-13.953506,"median":-8.145965,"eighty":-4.836613,"marketCap":2285107821.71},{"date":"2026-02-06","current":-19.628431,"twenty":-14.150386,"median":-8.145965,"eighty":-4.836613,"marketCap":2004887266.84},{"date":"2026-02-13","current":-21.333587,"twenty":-14.190059,"median":-8.145965,"eighty":-4.836613,"marketCap":2179055269.54},{"date":"2026-02-20","current":-21.489699,"twenty":-14.301157,"median":-8.145965,"eighty":-4.836613,"marketCap":2195000855.91},{"date":"2026-02-27","current":-21.752341,"twenty":-14.491969,"median":-8.145965,"eighty":-4.836613,"marketCap":2052768439.47},{"date":"2026-03-06","current":-21.973066,"twenty":-14.652,"median":-8.145965,"eighty":-4.836613,"marketCap":2073598194.45},{"date":"2026-03-13","current":-20.469582,"twenty":-14.911457,"median":-8.145965,"eighty":-4.836613,"marketCap":1931714499.61},{"date":"2026-03-20","current":-19.85972,"twenty":-15.021134,"median":-8.145965,"eighty":-4.836613,"marketCap":1874161791.28}],"updateTime":1774275233090},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MESO\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2590547736","title":"Independent Study Presented at American Society of Hematology (ASH) Annual Meeting Concludes Remestemcel-L Superior to Ruxolitinib in Clinical Outcomes as Treatment for SR-aGvHD","url":"https://stock-news.laohu8.com/highlight/detail?id=2590547736","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590547736?lang=en_us&edition=fundamental","pubTime":"2025-12-12 07:22","pubTimestamp":1765495320,"startTime":"0","endTime":"0","summary":"NEW YORK, Dec.  11, 2025  (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that an independent pe","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/11/3204384/0/en/Independent-Study-Presented-at-American-Society-of-Hematology-ASH-Annual-Meeting-Concludes-Remestemcel-L-Superior-to-Ruxolitinib-in-Clinical-Outcomes-as-Treatment-for-SR-aGvHD.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4197","BK4139","MESO","SR","ASH","BK4107","BK4150","MSB","SPN","AFG","BK4117","BK4006","LU2463526074.USD","MSC","BK4575","BK4109"],"gpt_icon":0},{"id":"2588020600","title":"Mesoblast Participation at Piper Sandler Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2588020600","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588020600?lang=en_us&edition=fundamental","pubTime":"2025-12-04 07:10","pubTimestamp":1764803400,"startTime":"0","endTime":"0","summary":"NEW YORK, Dec.  03, 2025  (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced its participation at t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/03/3199432/0/en/Mesoblast-Participation-at-Piper-Sandler-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MESO","MSB","BK4006","BK4150","BK4575","MSC"],"gpt_icon":0},{"id":"2586259969","title":"Mesoblast’s AGM Results: All Resolutions Passed on November 25, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2586259969","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586259969?lang=en_us&edition=fundamental","pubTime":"2025-11-26 19:33","pubTimestamp":1764156827,"startTime":"0","endTime":"0","summary":"Mesoblast ( ($MESO) ) has provided an announcement. On November 25, 2025, Mesoblast Limited announced the results of its Annual General Meeting, wh...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mesoblasts-agm-results-all-resolutions-passed-on-november-25-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mesoblasts-agm-results-all-resolutions-passed-on-november-25-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4195","AGM","MESO","BK4229"],"gpt_icon":0},{"id":"2586474997","title":"BRIEF-Mesoblast Expects Gross Revenue Of More Than $30.0 Mln From Sales Of Ryoncil For Quarter Ending Dec 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2586474997","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586474997?lang=en_us&edition=fundamental","pubTime":"2025-11-25 23:08","pubTimestamp":1764083338,"startTime":"0","endTime":"0","summary":"BRIEF-Mesoblast Expects Gross Revenue Of More Than $30.0 Mln From Sales Of Ryoncil For Quarter Ending Dec 31 Nov 25  - Mesoblast Ltd MSB.AX:MESOBLAST LTD - FOR QUARTER ENDING DECEMBER 31, 2025, EXPECTS GROSS REVENUE OF MORE THAN US$30.0 MILLION FROM SALES OF RYONCILSource text: [ID:n0001345099-25-000101]Further company coverage: MSB.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nFWN3X10UX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MESO","BK7067","MSB.AU","BK7508","BK4139","BK7501"],"gpt_icon":0},{"id":"2586474854","title":"Mesoblast Achieves FDA Approval for Ryoncil®","url":"https://stock-news.laohu8.com/highlight/detail?id=2586474854","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586474854?lang=en_us&edition=fundamental","pubTime":"2025-11-25 22:58","pubTimestamp":1764082704,"startTime":"0","endTime":"0","summary":"An update from Mesoblast ( ($MESO) ) is now available. On November 25, 2025, Mesoblast Limited announced at its Annual General Meeting that it has ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mesoblast-achieves-fda-approval-for-ryoncil?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mesoblast-achieves-fda-approval-for-ryoncil?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MESO","BK4139"],"gpt_icon":0},{"id":"2586471162","title":"Mesoblast Ltd - for Quarter Ending December 31, 2025, Expects Gross Revenue of More Than US$30.0 Million From Sales of Ryoncil","url":"https://stock-news.laohu8.com/highlight/detail?id=2586471162","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586471162?lang=en_us&edition=fundamental","pubTime":"2025-11-25 22:44","pubTimestamp":1764081869,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nFWN3X10UX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK4139","BK7501","BK7067","MESO","MSB.AU"],"gpt_icon":0},{"id":"2586676476","title":"Mesoblast Raised to Buy From Hold by Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2586676476","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586676476?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:48","pubTimestamp":1764078480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MESO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 25, 2025 08:48 ET (13:48 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MESO"],"gpt_icon":0},{"id":"2586421222","title":"Mesoblast upgraded to Buy from Hold at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2586421222","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586421222?lang=en_us&edition=fundamental","pubTime":"2025-11-25 18:35","pubTimestamp":1764066918,"startTime":"0","endTime":"0","summary":"Jefferies upgraded Mesoblast (MESO) to Buy from Hold with a price target of A$3.30, up from A$3. Published first on TheFly – the ultimate source fo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mesoblast-upgraded-to-buy-from-hold-at-jefferies-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mesoblast-upgraded-to-buy-from-hold-at-jefferies-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MESO"],"gpt_icon":0},{"id":"2586416251","title":"Mesoblast Reports 37% Quarter-on-Quarter Revenue Growth From Ryoncil; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586416251","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586416251?lang=en_us&edition=fundamental","pubTime":"2025-11-25 07:53","pubTimestamp":1764028419,"startTime":"0","endTime":"0","summary":"Mesoblast  reported that gross revenue from Ryoncil sales is expected to exceed $30 million for the December quarter, marking over 37% increase from $21.9 million in the September quarter, according to a Tuesday Australian bourse filing.The company's shares rose around 3% in recent Tuesday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MESO"],"gpt_icon":0},{"id":"2586416150","title":"Press Release: Mesoblast Trading Update at Annual General Meeting Highlights Continued Strong Growth in Ryoncil(R) Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2586416150","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586416150?lang=en_us&edition=fundamental","pubTime":"2025-11-25 07:39","pubTimestamp":1764027540,"startTime":"0","endTime":"0","summary":"NEW YORK, Nov. 24, 2025  -- Mesoblast Limited , global leader in allogeneic cellular medicines for inflammatory diseases, today provided a trading update, together with a comprehensive operational overview, as part of the Chief Executive's Annual General Meeting  address.For the quarter ending December 31, 2025, management expects gross revenue of more than US$30.0 million from sales of Ryoncil . This represents more than 37% increase on the US$21.9 million in gross revenue from Ryoncil in the prior quarter ended September 30, 2025.Mesoblast  is a world leader in developing allogeneic  cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The therapies from the Company's proprietary mesenchymal lineage cell therapy technology platform respond to severe inflammation by releasing anti-inflammatory factors that counter and modulate multiple effector arms of the immune system, resulting in significant reduction of the damaging inflammatory process.Mes","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MESO","R"],"gpt_icon":0},{"id":"2585457162","title":"Mesoblast to Conduct Pivotal Ryoncil Trial in Adults With Severe Acute Graft Versus Host Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2585457162","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585457162?lang=en_us&edition=fundamental","pubTime":"2025-11-21 09:36","pubTimestamp":1763688983,"startTime":"0","endTime":"0","summary":"Mesoblast  will collaborate with the Blood and Marrow Transplant Clinical Trials Network on a pivotal trial of Ryoncil as part of a first-line regimen in adults with severe acute graft versus host disease refractory to corticosteroids, according to a Friday Australian bourse filing.The patients will be randomized in the trial as early as possible after corticosteroid refractoriness to receive ruxolitinib alone or combined with Ryoncil to give them the best chance of survival.The trial protocol will be provided to the US Food and Drug Administration to initiate enrollment in the first quarter of 2026. Mesoblast recently met with the US FDA to discuss the most appropriate patient population and timing of treatment in a pivotal trial of Ryoncil for adults with severe acute graft versus host disease.Ryoncil is already approved by the FDA in children and adolescents.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","HST","MESO","BK4181","BK7067","MSB.AU","BK7501","BK4588","BK4585","BK7508","BK4218"],"gpt_icon":0},{"id":"2585166564","title":"Mesoblast and BMT CTN to Initiate Pivotal Trial of Ryoncil® as Part of First-Line Regimen in Adults with Severe Acute GVHD Refractory to Steroids","url":"https://stock-news.laohu8.com/highlight/detail?id=2585166564","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585166564?lang=en_us&edition=fundamental","pubTime":"2025-11-21 07:32","pubTimestamp":1763681520,"startTime":"0","endTime":"0","summary":"NEW YORK, Nov.  20, 2025  (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that given the high ra","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/20/3192470/0/en/Mesoblast-and-BMT-CTN-to-Initiate-Pivotal-Trial-of-Ryoncil-as-Part-of-First-Line-Regimen-in-Adults-with-Severe-Acute-GVHD-Refractory-to-Steroids.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4192","BK4150","BK4539","MESO","BK4575","BK4535","MCW","BK4006","MSB","BK4139","MSC"],"gpt_icon":0},{"id":"2584440766","title":"Mesoblast appoints James O’Brien as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2584440766","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584440766?lang=en_us&edition=fundamental","pubTime":"2025-11-17 18:45","pubTimestamp":1763376322,"startTime":"0","endTime":"0","summary":"Mesoblast (MESO) announced that in connection with the company’s transition to a fully integrated commercial organization it has appointed James O’...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mesoblast-appoints-james-obrien-as-cfo-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mesoblast-appoints-james-obrien-as-cfo-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MESO","BK4139"],"gpt_icon":0},{"id":"2584646044","title":"Mesoblast Appoints James O'Brien CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2584646044","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584646044?lang=en_us&edition=fundamental","pubTime":"2025-11-17 17:43","pubTimestamp":1763372632,"startTime":"0","endTime":"0","summary":"Mesoblast (MESO) said Monday it has appointed James O'Brien as its chief financial officer.O'Brien previously worked at different pharmaceutical companies, including Bristol-Myers Squibb (BMY) and Cognition Therapeutics (CGTX), the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1868836757.USD","BK4534","LU1868837300.USD","LU0456855351.SGD","BK4559","LU0096364046.USD","LU0306806265.USD","LU2242646821.SGD","LU0321505439.SGD","LU1430594728.SGD","LU1571399168.USD","IE00BJJMRZ35.SGD","LU1291159041.SGD","LU1670711040.USD","LU1718418525.SGD","BK4007","CGTX","LU1670711123.USD","LU2360032135.SGD","BK4532","LU2125154935.USD","LU2133065610.SGD","LU0225771236.USD","BK4585","LU0306807586.USD","LU0061475181.USD","LU1868837136.USD","IE00BFXG1179.USD","LU1074936037.SGD","LU0321505868.SGD","IE00BSNM7G36.USD","LU1093756168.USD","LU1989771016.USD","IE00B2B36J28.USD","IE0002141913.USD","LU0882574055.USD","LU1261432733.SGD","IE00BJT1NW94.SGD","LU1585245621.USD","MESO","LU1093756325.SGD","LU2125154778.USD","LU0237698245.USD","IE00BFTCPJ56.SGD","LU0868494617.USD","LU1670710661.SGD","LU2242652126.USD","LU0225284248.USD","BMY","BK4139"],"gpt_icon":0},{"id":"2584737614","title":"Press Release: James M. O'Brien Appointed Chief Financial Officer at Mesoblast","url":"https://stock-news.laohu8.com/highlight/detail?id=2584737614","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584737614?lang=en_us&edition=fundamental","pubTime":"2025-11-17 14:52","pubTimestamp":1763362320,"startTime":"0","endTime":"0","summary":"NEW YORK, Nov. 17, 2025  -- Mesoblast Limited , global leader in allogeneic cellular medicines for inflammatory diseases, today announced that in connection with the Company's transition to a fully integrated commercial organization it has appointed James M. O'Brien as its US-based Chief Financial Officer . Jim has extensive experience in all aspects of financial management and planning having spent the majority of his career with multi-national public and private companies in the life sciences, biotechnology, and pharmaceutical industries.Mesoblast  is a world leader in developing allogeneic  cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The therapies from the Company's proprietary mesenchymal lineage cell therapy technology platform respond to severe inflammation by releasing anti-inflammatory factors that counter and modulate multiple effector arms of the immune system, resulting in significant red","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","R","BK4006","MSB","MSB.AU","CFO","MESO","BK4232","BK4022","BMS","BK4150","BK4139","MSC","BK4575","BK7508","BK7501"],"gpt_icon":0},{"id":"2584697095","title":"BRIEF-Mesoblast Appoints James M. O'brien As U.S.-Based CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2584697095","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584697095?lang=en_us&edition=fundamental","pubTime":"2025-11-17 09:47","pubTimestamp":1763344055,"startTime":"0","endTime":"0","summary":"BRIEF-Mesoblast Appoints James M. O'brien As U.S.-Based CFONov 17 (Reuters) - Mesoblast Ltd MSB.AX:APPOINTMENT OF CHIEF FINANCIAL OFFICERAPPOINTS JAMES M. O'BRIEN AS US-BASED CFOFurther company coverage: MSB.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nTUE2RGXVY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MESO","BK7067","BK7501","BK7508","BK4139","MSB.AU"],"gpt_icon":0},{"id":"2584697194","title":"Mesoblast Appoints New CFO Amidst Commercial Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2584697194","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584697194?lang=en_us&edition=fundamental","pubTime":"2025-11-17 09:38","pubTimestamp":1763343497,"startTime":"0","endTime":"0","summary":"Mesoblast Limited ( ($AU:MSB) ) has provided an update. Mesoblast Limited has appointed James M. O’Brien as its new Chief Financial Officer, a stra...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mesoblast-appoints-new-cfo-amidst-commercial-transition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mesoblast-appoints-new-cfo-amidst-commercial-transition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MESO"],"gpt_icon":0},{"id":"2584669489","title":"Mesoblast Appoints CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2584669489","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584669489?lang=en_us&edition=fundamental","pubTime":"2025-11-17 08:11","pubTimestamp":1763338304,"startTime":"0","endTime":"0","summary":"Mesoblast (ASX:MSB) appointed James M. O'Brien as chief financial officer, according to a Monday filing with the Australian bourse.The company's shares rose around 3% in recent Monday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","BK7508","MESO","XJO.AU","BK7501","XKO.AU","MSB.AU","BK7067","BK4139"],"gpt_icon":0},{"id":"2584699934","title":"Mesoblast Ltd - Appoints James M. O'brien as US-Based CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2584699934","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584699934?lang=en_us&edition=fundamental","pubTime":"2025-11-17 06:53","pubTimestamp":1763333629,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251116:nTUE2RGXVY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","MESO","MSB.AU","BK7501","BK7067","BK4139"],"gpt_icon":0},{"id":"2581279620","title":"Mesoblast to Meet With FDA Next Month to Discuss Rexlemestrocel-L and Opioid Cessation","url":"https://stock-news.laohu8.com/highlight/detail?id=2581279620","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581279620?lang=en_us&edition=fundamental","pubTime":"2025-11-05 07:40","pubTimestamp":1762299600,"startTime":"0","endTime":"0","summary":"NEW YORK, Nov.  04, 2025  (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that the U.S. Food & D","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/04/3181021/0/en/Mesoblast-to-Meet-With-FDA-Next-Month-to-Discuss-Rexlemestrocel-L-and-Opioid-Cessation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4546","DDD","BK4170","MSC","BK4150","BK4161","BK4551","MESO","BK4575","BK4139","BK4006","MSB"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":104,"code":"91000000","status":"200"}]}}